International Journal of Immunopathology and Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 65.6% | 0.718 | Q2 | 73.7% |
| 2024 | 2.6 | Q2 | 62.2% | 0.663 | Q2 | 71.8% |
| 2023 | 3.0 | Q2 | 62.5% | 0.611 | Q2 | 71.5% |
| 2022 | 3.5 | Q2 | 64.3% | 0.582 | Q2 | 71.0% |
| 2021 | 3.3 | Q3 | 55.7% | 0.528 | Q3 | 68.8% |
| 2020 | — | — | 0.724 | Q2 | 77.0% | |
| 2019 | — | — | 0.585 | Q2 | 71.9% | |
| 2018 | — | — | 0.643 | Q2 | 72.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2058-7384
ISSN
0394-6320
country
ITcoverage
1989-2026